Case CCC Research Teams Receive Awards

Teams from Case CCC and University Hospitals have received Collaborative Pilot Science Awards to conduct research on brain tumor, cerebral edema, and gastroesophageal cancer.

Each team received $50,000 funded by the UH-CWRU Joint Strategic Leadership Committee.

According to Daniel Simon, MD, UH's President, Academic & External Affairs and Chief Scientific Officer, the awards aim to inspire innovative and interdisciplinary research projects between the two institutions.

Stan Gerson, MD, Dean, CWRU School of Medicine, explained, "Decisions about these awards were made based on significance, originality, scientific merit; experience and capability of the proposing faculty; relevance to collaborative science leading to a strong federal grant application; and ability to carry out proposed research in one year."

Projects involving Case CCC members are: Bradykinin formation in malaria cerebral edema, Alvin Schmaier, MD, Molecular Oncology Program, Natural killer cells in combination with TGFbeta targeted therapies in gastroesophageal cancer, Andrew Blum, MD, PhD, and Kishore Guda, DVM, PhD, Cancer Genomics and Epigenomics Program, Eva Selfridge, MD, PhD, Population and Cancer Prevention Program, and David Wald, MD, PhD, Co-Leader, Immune Oncology Program; and Novel immunotherapies targeting a unique biomarker in the tumor microenvironment, Susann Brady-Kalnay, PhD, Cancer Imaging Program, and David Wald, MD, PhD.